We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




World's First Cooperatively Powered Robotic Surgical Assistant Platform Facilitates ENT Procedures

By HospiMedica International staff writers
Posted on 27 Sep 2023

While medical robots are becoming more common in surgical settings, there are still many surgeons who perform operations manually, relying on their skills to stabilize their hands and minimize tremors. More...

Now a new surgical robotic assistant is designed to assist such surgeons in soft tissue surgeries by acting as a support for performing ear, nose, and throat (ENT) surgeries.

Galen Robotics (Baltimore, MD, USA) has developed the Galen ES robotic system which is the world’s first cooperatively powered surgical assist device for ENT surgery. The system helps ENT surgeons with tasks like instrument positioning in combination with Microlaryngeal Alligator Forceps. The device synchronizes with the surgeon's actions to aid in the precise and stable positioning of surgical instruments, all while the surgeon retains direct physical control over them. The aim of the Galen ES system is to offer increased stability for instruments in complex microlaryngeal surgeries, enabling otolaryngologists to potentially deliver better patient outcomes with its high functionality and quick setup time.

The Galen ES system is designed to assist surgeons in moving the Microlaryngeal Alligator Forceps to a chosen location within the surgical area and keep it in place until the surgeon decides to move it. The system is meant for use in rigid microlaryngeal surgeries carried out by skilled otolaryngologists on patients who are at least 18 years old and are in an operating room environment. After securing a De Novo classification grant and market authorization from the U.S. Food and Drug Administration (FDA) for the Galen ES robotic system for use in rigid microlaryngeal procedures, Galen Robotics aims to push the boundaries of surgical medicine. The company is focused on innovating surgical methods and offering groundbreaking solutions to healthcare providers. The primary objective of Galen's technology is to assist in surgeries where operating room space is restricted and sensitive anatomical structures must be handled with extreme care.

"Our team is incredibly proud the Galen ES Robotic System was granted FDA clearance in record time," announced Bruce W Lichorowic, President & CEO of Galen Robotics, Inc. "The Galen ES System holds great promise in revolutionizing challenging ENT surgeries by providing existing surgical instruments with its advanced features that empower skilled ENT surgeons. We anticipate significantly improved surgical precision and better patient outcomes."

Related Links:
Galen Robotics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.